Could a lung cancer drug work for rare tumors? new trial aims to find out
NCT ID NCT05770037
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called alectinib, already approved for some lung cancers, in people with rare cancers that have a specific genetic change called ALK. About 30 adults, teens, and children with ALK-positive cancers will receive alectinib to see if it shrinks tumors or stops them from growing. The goal is to find new uses for existing drugs in hard-to-treat cancers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAPLASTIC LARGE CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Addenbrooke's Hospital
RECRUITINGCambridge, CB2 OQQ, United Kingdom
-
Alder Hey Hospital
RECRUITINGLiverpool, L14 5AB, United Kingdom
-
Belfast City Hospital
RECRUITINGBelfast, BT9 7AB, United Kingdom
-
Birmingham Children's Hospital
NOT_YET_RECRUITINGBirmingham, United Kingdom
-
Bristol Haematology and Oncology Centre
RECRUITINGBristol, BS2 8ED, United Kingdom
-
Bristol Royal Hospital for Children
RECRUITINGBristol, BS2 8BJ, United Kingdom
-
Cardiff Children's Hospital
NOT_YET_RECRUITINGCardiff, CF14 4XW, United Kingdom
-
Churchill Hospital
RECRUITINGOxford, OX3 7LE, United Kingdom
-
Clatterbridge Cancer Centre
RECRUITINGMetropolitan Borough of Wirral, CH63 4JY, United Kingdom
-
Freeman Hospital
RECRUITINGNewcastle, NE7 7DN, United Kingdom
-
Great North Children's Hospital
RECRUITINGNewcastle, NE1 4LP, United Kingdom
-
Great Ormond Street Hospital
RECRUITINGLondon, WC1N 3JH, United Kingdom
-
Guy's Hospital
RECRUITINGLondon, SE1 9RT, United Kingdom
-
John Radcliffe Hospital
RECRUITINGOxford, OX3 9DU, United Kingdom
-
Leicester Royal Infirmary
RECRUITINGLeicester, LE1 5WW, United Kingdom
-
Royal Hospital for Children Glasgow
RECRUITINGGlasgow, G51 4TF, United Kingdom
-
Royal Manchester Children's Hospital
NOT_YET_RECRUITINGManchester, M13 9WL, United Kingdom
-
Sheffield's Children's Hospital
RECRUITINGSheffield, S10 2TH, United Kingdom
-
Southampton General Hospital
RECRUITINGSouthampton, SO16 6YD, United Kingdom
-
The Beatson Hospital
RECRUITINGGlasgow, G12 OYN, United Kingdom
-
The Christie Hospital
RECRUITINGManchester, M20 4BX, United Kingdom
-
The Royal Marsden Hospital
RECRUITINGSutton, SM2 5PT, United Kingdom
-
University College London Hospital
RECRUITINGLondon, NW1 2BU, United Kingdom
-
University Hospital Birmingham
RECRUITINGBirmingham, B15 2TT, United Kingdom
-
Velindre Cancer Centre
RECRUITINGCardiff, CF14 2TL, United Kingdom
-
Western General Hospital
RECRUITINGEdinburgh, EH4 2XU, United Kingdom
-
Weston Park Hospital
RECRUITINGSheffield, S10 2SJ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could muscle loss predict blood cancer outcomes?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare